Petros Pharmaceuticals Inc (PTPI)
0.58
+0.03
(+5.82%)
USD |
NASDAQ |
May 17, 16:00
0.58
0.00 (0.00%)
After-Hours: 20:00
Petros Pharmaceuticals Total Long Term Debt (Quarterly): 8.014M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 8.014M |
September 30, 2023 | 8.388M |
June 30, 2023 | 8.757M |
March 31, 2023 | 9.120M |
December 31, 2022 | 9.478M |
September 30, 2022 | 9.663M |
June 30, 2022 | 10.02M |
March 31, 2022 | 10.20M |
Date | Value |
---|---|
December 31, 2021 | 0.00 |
September 30, 2021 | 1.741M |
June 30, 2021 | 3.425M |
March 31, 2021 | 5.061M |
December 31, 2020 | 7.175M |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
10.20M
Maximum
Mar 2022
5.690M
Average
7.594M
Median
Total Long Term Debt (Quarterly) Benchmarks
Avalo Therapeutics Inc | -- |
Imunon Inc | -- |
iBio Inc | -- |
Ocugen Inc | 2.829M |
Gritstone Bio Inc | 40.33M |